Shun Lu, Doctor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Shanghai Chest Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shun Lu, Doctor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:26 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06927986 · Phase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC（SYNSTAR01）CSPC Megalith Biopharmaceutical Co.,Ltd. · recruiting · EGFR-mutated Locally Advanced or Metastatic NSCLC · principal investigator
- Ph2NCT05374603 · Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLCAstraZeneca · active not recruiting · Lung Cancer · principal investigator
- Ph1NCT05223595 · A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLCChangchun GeneScience Pharmaceutical Co., Ltd. · unknown · Metastatic Non-Small Cell Lung Cancer · principal investigator
- Ph1NCT04866485 · A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 AntibodyHarbour BioMed (Guangzhou) Co. Ltd. · unknown · Solid Tumor · principal investigator
- Ph1NCT03976856 · Safety and Efficacy of Genolimzumab (GB226) in Combination With FruquintinibGenor Biopharma Co., Ltd. · unknown · Metastatic Non-small Cell Lung Cancer · principal investigator
- Ph2NCT02897479 · A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung CancerHutchison Medipharma Limited · unknown · Lung Sarcomatoid Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.